Cargando…
International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005
The International Circumpolar Surveillance System is a population-based surveillance network for invasive bacterial disease in the Arctic. The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for routine infant vaccination in Alaska (2001), northern Canada (2002–2006), and Norway (2006)...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600171/ https://www.ncbi.nlm.nih.gov/pubmed/18258073 http://dx.doi.org/10.3201/eid1401.071315 |
_version_ | 1782162124537069568 |
---|---|
author | Bruce, Michael G. Deeks, Shelley L. Zulz, Tammy Bruden, Dana Navarro, Christine Lovgren, Marguerite Jette, Louise Kristinsson, Karl Sigmundsdottir, Gudrun Jensen, Knud Brinkløv Lovoll, Oistein Nuorti, J. Pekka Herva, Elja Nystedt, Anders Sjostedt, Anders Koch, Anders Hennessy, Thomas W. Parkinson, Alan J. |
author_facet | Bruce, Michael G. Deeks, Shelley L. Zulz, Tammy Bruden, Dana Navarro, Christine Lovgren, Marguerite Jette, Louise Kristinsson, Karl Sigmundsdottir, Gudrun Jensen, Knud Brinkløv Lovoll, Oistein Nuorti, J. Pekka Herva, Elja Nystedt, Anders Sjostedt, Anders Koch, Anders Hennessy, Thomas W. Parkinson, Alan J. |
author_sort | Bruce, Michael G. |
collection | PubMed |
description | The International Circumpolar Surveillance System is a population-based surveillance network for invasive bacterial disease in the Arctic. The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for routine infant vaccination in Alaska (2001), northern Canada (2002–2006), and Norway (2006). Data for invasive pneumococcal disease (IPD) were analyzed to identify clinical findings, disease rates, serotype distribution, and antimicrobial drug susceptibility; 11,244 IPD cases were reported. Pneumonia and bacteremia were common clinical findings. Rates of IPD among indigenous persons in Alaska and northern Canada were 43 and 38 cases per 100,000 population, respectively. Rates in children <2 years of age ranged from 21 to 153 cases per 100,000 population. In Alaska and northern Canada, IPD rates in children <2 years of age caused by PCV7 serotypes decreased by >80% after routine vaccination. IPD rates are high among indigenous persons and children in Arctic countries. After vaccine introduction, IPD caused by non-PCV7 serotypes increased in Alaska. |
format | Text |
id | pubmed-2600171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-26001712009-01-13 International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 Bruce, Michael G. Deeks, Shelley L. Zulz, Tammy Bruden, Dana Navarro, Christine Lovgren, Marguerite Jette, Louise Kristinsson, Karl Sigmundsdottir, Gudrun Jensen, Knud Brinkløv Lovoll, Oistein Nuorti, J. Pekka Herva, Elja Nystedt, Anders Sjostedt, Anders Koch, Anders Hennessy, Thomas W. Parkinson, Alan J. Emerg Infect Dis Research The International Circumpolar Surveillance System is a population-based surveillance network for invasive bacterial disease in the Arctic. The 7-valent pneumococcal conjugate vaccine (PCV7) was introduced for routine infant vaccination in Alaska (2001), northern Canada (2002–2006), and Norway (2006). Data for invasive pneumococcal disease (IPD) were analyzed to identify clinical findings, disease rates, serotype distribution, and antimicrobial drug susceptibility; 11,244 IPD cases were reported. Pneumonia and bacteremia were common clinical findings. Rates of IPD among indigenous persons in Alaska and northern Canada were 43 and 38 cases per 100,000 population, respectively. Rates in children <2 years of age ranged from 21 to 153 cases per 100,000 population. In Alaska and northern Canada, IPD rates in children <2 years of age caused by PCV7 serotypes decreased by >80% after routine vaccination. IPD rates are high among indigenous persons and children in Arctic countries. After vaccine introduction, IPD caused by non-PCV7 serotypes increased in Alaska. Centers for Disease Control and Prevention 2008-01 /pmc/articles/PMC2600171/ /pubmed/18258073 http://dx.doi.org/10.3201/eid1401.071315 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Bruce, Michael G. Deeks, Shelley L. Zulz, Tammy Bruden, Dana Navarro, Christine Lovgren, Marguerite Jette, Louise Kristinsson, Karl Sigmundsdottir, Gudrun Jensen, Knud Brinkløv Lovoll, Oistein Nuorti, J. Pekka Herva, Elja Nystedt, Anders Sjostedt, Anders Koch, Anders Hennessy, Thomas W. Parkinson, Alan J. International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 |
title | International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 |
title_full | International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 |
title_fullStr | International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 |
title_full_unstemmed | International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 |
title_short | International Circumpolar Surveillance System for Invasive Pneumococcal Disease, 1999–2005 |
title_sort | international circumpolar surveillance system for invasive pneumococcal disease, 1999–2005 |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2600171/ https://www.ncbi.nlm.nih.gov/pubmed/18258073 http://dx.doi.org/10.3201/eid1401.071315 |
work_keys_str_mv | AT brucemichaelg internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT deeksshelleyl internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT zulztammy internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT brudendana internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT navarrochristine internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT lovgrenmarguerite internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT jettelouise internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT kristinssonkarl internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT sigmundsdottirgudrun internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT jensenknudbrinkløv internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT lovolloistein internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT nuortijpekka internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT hervaelja internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT nystedtanders internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT sjostedtanders internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT kochanders internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT hennessythomasw internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT parkinsonalanj internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 AT internationalcircumpolarsurveillancesystemforinvasivepneumococcaldisease19992005 |